Objective To investigate the correlation between bioavailable 1,25-hydroxyvitamin D [1,25(OH)2D] level and bone mineral density(BMD) and bone metabolic markers in patients with nephrotic syndrome(NS). Methods A total of 80 NS patients(NS group) and 60 healthy subjects(healthy control group) with similar sex,age and body mass index(BMI) were enrolled. The data on sex,age,height,weight,blood pressure,smoking history and drinking history of all the subjects were recorded,and BMI was calculated. The BMD,serum creatinine(SCr),total cholesterol(TC),triglyceride(TG),albumin(Alb),calcium,phosphorus,intact parathyroid hormone(iPTH),total 1,25(OH)2D and vitamin D binding protein(DBP) were determined,and bioavailable 1,25(OH)2D was calculated. Multivariate Logistic regression analysis was used to evaluate the correlations between the indicators and 1,25(OH)2D levels. Results The systolic blood pressure,serum Alb,Ca,total 1,25(OH)2D and bioavailable 1,25(OH)2D levels in NS group were lower than those in healthy control group(P<0.05),and the diastolic blood pressure and serum TC,TG,phosphorus and iPTH were higher than those in healthy control group(P<0.05). There was no statistical significance between the 2 groups in smoking history ratio,drinking history ratio,SCr,estimated glomerular filtration rate(eGFR),serum DBP and BMD (P>0.05). Total 1,25(OH)2D and bioavailable 1,25(OH)2D levels in NS group were positively correlated with BMD,Alb and DBP(P<0.01) and were negatively correlated with iPTH and TC(P<0.01),and there was no correlation with the other indicators(P>0.05). Conclusions Low levels of total 1,25(OH)2D and bioavailable 1,25(OH)2D in NS group are related to BMD and bone metabolic markers.